Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma
Authors
Keywords
-
Journal
JOURNAL OF ASTHMA
Volume 52, Issue 10, Pages 1073-1083
Publisher
Informa UK Limited
Online
2015-12-09
DOI
10.3109/02770903.2015.1056350
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-Review: Adverse Effects of Inhaled Corticosteroids Relevant to Older Patients
- (2014) Katharina Mattishent et al. DRUGS
- Measurement properties of an asthma symptom and rescue medication use diary
- (2014) Marci Clark et al. JOURNAL OF ASTHMA
- Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study
- (2014) Ashley Woodcock et al. BMC Pulmonary Medicine
- Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial
- (2014) Eugene R. Bleecker et al. Journal of Allergy and Clinical Immunology-In Practice
- Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
- (2013) P. M. O'Byrne et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
- (2013) William W Busse et al. THORAX
- Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
- (2013) Eric D Bateman et al. THORAX
- Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids
- (2012) Eugene R. Bleecker et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids
- (2012) Jan Lötvall et al. EUROPEAN RESPIRATORY JOURNAL
- Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
- (2012) Eric D. Bateman et al. RESPIRATORY MEDICINE
- Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial
- (2012) Richard Sterling et al. RESPIRATORY MEDICINE
- Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial
- (2011) William W Busse et al. THORAX
- Treatment with Inhaled Mometasone Furoate Reduces Short-Acting β2 Agonist Claims and Increases Adherence Compared to Fluticasone Propionate in Asthma Patients
- (2011) Prakash Navaratnam et al. VALUE IN HEALTH
- The influence of personality traits and beliefs about medicines on adherence to asthma treatment
- (2011) Maria Emilsson et al. Primary Care Respiratory Journal
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
- (2010) Jan L. Brożek et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma
- (2010) Howard S. Friedman et al. JOURNAL OF ASTHMA
- Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
- (2010) David Price et al. BMC Pulmonary Medicine
- The minimally important difference of the Asthma Control Test
- (2009) Michael Schatz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now